Načítá se...
Cytokines that target immune killer cells against tumors
T-cell-stimulating cytokines have shown promise as monotherapies or in combination with other therapeutic modalities for immunotherapy of cancer. However, their efficacy is limited due to their short half-life, pleiotropic roles, and induction of severe toxicity even at therapeutic doses. To overcom...
Uloženo v:
| Vydáno v: | Cell Mol Immunol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group UK
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7331613/ https://ncbi.nlm.nih.gov/pubmed/32523115 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41423-020-0481-0 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|